Teva may have new CEO on deck

Share this article:

Teva is rumored to be close to naming a new CEO, after a tumultuous few months that included the October announcement it was firing 10% of its staff, followed just weeks later with the public departure of then-CEO Jeremy Levin. Whether Levin was pushed or left on his own accord depends on the interviewee, but Eyal Deshesh has filled the role for the last several months.

Bloomberg reported Monday that board member Erez Vigodman is favored for the title, while BioCentury said Friday that Teva would not comment on whether the CEO of agrochemical firm Makhtshim Agan was in line for the job.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.